Neoadjuvant therapy for melanoma: A critical appraisal Review
| Authors: | McKinley, S. K.; Brady, M. S. |
| Review Title: | Neoadjuvant therapy for melanoma: A critical appraisal |
| Abstract: | The treatment of advanced melanoma has significantly changed since the development of targeted and immune therapy. To date, these agents have primarily been used in the adjuvant or metastatic setting. Given several theoretical advantages, there is increased interest in the use of these new therapeutics in the neoadjuvant setting. In this review, we detail the potential benefits and pitfalls of neoadjuvant therapy for melanoma, review the currently available data, and describe ongoing neoadjuvant trials. © 2022 Wiley Periodicals LLC. |
| Keywords: | treatment response; cancer surgery; unclassified drug; overall survival; review; cancer adjuvant therapy; neoadjuvant therapy; cancer staging; antineoplastic agent; lymph node dissection; melanoma; immunotherapy; tumor protein; neoadjuvant; theoretical study; recurrence free survival; human; lymphocyte activation gene 3 |
| Journal Title: | Journal of Surgical Oncology |
| Volume: | 127 |
| Issue: | 1 |
| ISSN: | 0022-4790 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2023-01-01 |
| Start Page: | 132 |
| End Page: | 139 |
| Language: | English |
| DOI: | 10.1002/jso.27089 |
| PUBMED: | 36121419 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Review -- Export Date: 3 January 2023 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work